Departed
David Lazar
Sole Officer and Director
BRRN ·
Byrn, Inc.
Mr. Lazar resigned on April 24, 2026 from his positions as sole officer and director of the Registrant.
Ready 8-Ks
2
Latest filing
September 16, 2026, 8:00 AM ET
Top materiality
0.75
Event mix
other_material ×1 · leadership ×1
Sentiment
0 pos · 0 neg · 2 neu
Executive change
recent →
Recent 8-K filings for BRRN
Highest-materiality recent filing
Bryn Inc. undergoes change in control; MEDO Healthcare acquires 84.7% voting power, new CEO appointed
- On April 24, 2026, MEDO Healthcare LLC purchased 10M shares of Series A-1 Preferred Stock for $175,000 cash, gaining 84.7% voting power.
- David Lazar resigned as sole officer/director; John Leo appointed as sole director and CEO, Arthur Magee as CFO and Secretary.
-
Bryn Inc. to change name to MEDO Technologies, 1-for-100,000 reverse split effective Sept 23
Name change to MEDO Technologies, Inc. effective Sept 23, 2026 at 6:00 PM PDT.
-
On April 24, 2026, MEDO Healthcare LLC purchased 10M shares of Series A-1 Preferred Stock for $175,000 cash, gaining 84.7% voting power.
Executive changes
Appointed
Arthur Magee
Chief Financial Officer and Secretary
BRRN ·
Byrn, Inc.
Mr. Lazar also appointed Arthur Magee, an affiliate of John Leo, to serve upon Mr. Lazar’s resignation as CFO and Secretary of the Registrant.
Appointed
John Leo
Sole Director and Chief Executive Officer
BRRN ·
Byrn, Inc.
Mr. Lazar appointed John Leo to serve upon Mr. Lazar’s resignation as sole director and CEO of the Registrant.
Materiality & sentiment trend
Max materiality 0.75 · Median 0.62 · Most common event other_material